У нас вы можете посмотреть бесплатно Development of metallo-beta-lactamase inhibitors - Dr. Máté Erdélyi или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Webinar given by Dr. Máté Erdélyi at the Uppsala Antibiotic Center's seminar series on Friday December 3rd. Our most common antibiotics are the β-lactam containing ones, such as the penicillins and cephalosporins. In response to their wide use, bacteria have acquired the ability to produce β-lactamases that inactivate β-lactam antibiotics. Metallo-β-lactamases are an especially problematic group of enzymes as these hydrolyze nearly all known β-lactam antibiotics, including carbapenems, which are our last resort drugs. There are very few known metallo-β-lactamase inhibitors, and none of them is clinically applicable. In this talk I will show examples of our research on the development of metallo-β-lactamase inhibitors. These molecules are designed to protect β-lactam antibiotics and thereby allow their extended use in form of combination therapies. I will show examples for the design and synthesis of inhibitors of NDM-1, VIM-2 and CcrA, the evaluation of their bioactivities and the NMR spectroscopic determination of their protein binding site. If you are interested in our center's upcoming activities, please check https://uac.uu.se